|
EP0921196A1
(en)
*
|
1997-12-02 |
1999-06-09 |
Roche Diagnostics GmbH |
Modified DNA-polymerase from carboxydothermus hydrogenoformans and its use for coupled reverse transcription and polymerase chain reaction
|
|
EP0922765B1
(en)
*
|
1997-12-02 |
2005-11-23 |
Roche Diagnostics GmbH |
Modified DNA-polymerase from carboxydothermus hydrogenoformans and its use for coupled reverse transcription and polymerase chain reaction
|
|
US20030228616A1
(en)
*
|
1999-10-29 |
2003-12-11 |
Stratagene |
DNA polymerase mutants with reverse transcriptase activity
|
|
US20040009486A1
(en)
*
|
1999-10-29 |
2004-01-15 |
Sorge Joseph A. |
Compositions and methods utilizing DNA polymerases
|
|
US20050123940A1
(en)
*
|
1999-10-29 |
2005-06-09 |
Stratagene California |
Compositions and methods for synthesizing cDNA
|
|
WO2006033665A1
(en)
|
2004-03-16 |
2006-03-30 |
Inist Inc. |
Tat-based vaccine compositions and methods of making and using same
|
|
ATE427992T1
(de)
*
|
2001-11-14 |
2009-04-15 |
Toyo Boseki |
Dna-synthesepromotoren, mit dna-polymerase assoziierte faktoren und nutzung davon
|
|
BRPI0408967B8
(pt)
|
2003-03-31 |
2021-07-27 |
Hoffmann La Roche |
kit e métodos para detecção de um ácido nucléico de vários membros do sorogrupo do vírus da encefalite japonesa em uma amostra biológica sob condições de hibridização rigorosas
|
|
US8962293B2
(en)
|
2006-10-18 |
2015-02-24 |
Roche Molecular Systems, Inc. |
DNA polymerases and related methods
|
|
ES2432863T3
(es)
|
2009-03-23 |
2013-12-05 |
Pin Pharma, Inc. |
Tratamiento del cáncer con polipéptidos inmunoestimuladores derivados de Tat del VIH
|
|
CN103025867B
(zh)
|
2010-06-18 |
2015-05-20 |
霍夫曼-拉罗奇有限公司 |
具有增强的3’-错配辨别力的dna聚合酶
|
|
EP2582806B1
(en)
|
2010-06-18 |
2015-12-16 |
Roche Diagnostics GmbH |
Dna polymerases with increased 3'-mismatch discrimination
|
|
EP2582807B1
(en)
|
2010-06-18 |
2015-03-18 |
Roche Diagnostics GmbH |
Dna polymerases with increased 3'-mismatch discrimination
|
|
CA2802304C
(en)
|
2010-06-18 |
2016-01-12 |
F.Hoffman-La Roche Ag |
Dna polymerases with increased 3'-mismatch discrimination
|
|
WO2011157436A1
(en)
|
2010-06-18 |
2011-12-22 |
Roche Diagnostics Gmbh |
Dna polymerases with increased 3'-mismatch discrimination
|
|
WO2011157432A1
(en)
|
2010-06-18 |
2011-12-22 |
Roche Diagnostics Gmbh |
Dna polymerases with increased 3'-mismatch discrimination
|
|
EP2582802B1
(en)
|
2010-06-18 |
2016-01-13 |
Roche Diagnostics GmbH |
Dna polymerases with increased 3'-mismatch discrimination
|
|
US8759062B2
(en)
|
2010-06-18 |
2014-06-24 |
Roche Molecular Systems, Inc. |
DNA polymerases with increased 3′- mismatch discrimination
|
|
EP2675897B1
(en)
|
2011-02-15 |
2016-05-11 |
Roche Diagnostics GmbH |
Dna polymerases with increased 3'-mismatch discrimination
|
|
EP2697372B1
(en)
|
2011-04-11 |
2015-12-16 |
Roche Diagnostics GmbH |
Dna polymerases with improved activity
|
|
US9090883B2
(en)
|
2011-07-28 |
2015-07-28 |
Roche Molecular Systems, Inc. |
DNA polymerases with improved activity
|
|
WO2013083262A1
(en)
|
2011-12-08 |
2013-06-13 |
Roche Diagnostics Gmbh |
Dna polymerases with improved activity
|
|
JP6144697B2
(ja)
|
2011-12-08 |
2017-06-07 |
エフ．ホフマン−ラ ロシュ アーゲーＦ． Ｈｏｆｆｍａｎｎ−Ｌａ Ｒｏｃｈｅ Ａｋｔｉｅｎｇｅｓｅｌｌｓｃｈａｆｔ |
改善された活性を有するｄｎａポリメラーゼ
|
|
ES2569723T3
(es)
|
2011-12-08 |
2016-05-12 |
F. Hoffmann-La Roche Ag |
Polimerasas de DNA con actividad mejorada
|
|
US9663556B2
(en)
|
2013-10-04 |
2017-05-30 |
Pin Pharma, Inc. |
Treatment of cancers with immunostimulatory HIV tat derivative polypeptides
|
|
WO2019180137A1
(en)
|
2018-03-21 |
2019-09-26 |
F. Hoffmann-La Roche Ag |
Dna polymerases for efficient and effective incorporation of methylated-dntps
|
|
CN112703248B
(zh)
|
2018-09-13 |
2025-03-25 |
豪夫迈·罗氏有限公司 |
具有改良链置换能力的突变型dna聚合酶
|
|
CN111733145A
(zh)
*
|
2020-07-01 |
2020-10-02 |
济南国科医工科技发展有限公司 |
重组酶的纯化方法
|